Abstract
Undifferentiated cells, known as stem cells, have the capacity to self-renew and specialise in a variety of distinct mature and functional cell types while still retaining their original identity. For their significance in regenerative medicine, stem cells' deep potential has been widely examined, and this work has established the groundwork for cell-based therapeutics. With the potential to repair and restore specific organs or tissue injuries or chronic disease situations when the body's regenerative process is insufficient to heal, regenerative medicine is quickly advancing in healthcare. The most recent developments in stem cell-based treatments for regenerative medicine are covered in this review, focusing on mesenchymal stem cell-based treatments because these cells have received the most clinical research. The most recent applications of artificial intelligence algorithms in stem cell-based therapeutics are presented, along with their limitations and potential future applications.
Keywords: Artificial intelligence, stem cell, regenerative medicine, embryonic stem cells, mesenchymal stem cells, computational biology.
Current Pharmaceutical Design
Title:Developments in Stem Cell Therapy by Utilizing Artificial Intelligence
Volume: 29 Issue: 28
Author(s): Priyanshi Goyal and Rishabha Malviya*
Affiliation:
- Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India
Keywords: Artificial intelligence, stem cell, regenerative medicine, embryonic stem cells, mesenchymal stem cells, computational biology.
Abstract: Undifferentiated cells, known as stem cells, have the capacity to self-renew and specialise in a variety of distinct mature and functional cell types while still retaining their original identity. For their significance in regenerative medicine, stem cells' deep potential has been widely examined, and this work has established the groundwork for cell-based therapeutics. With the potential to repair and restore specific organs or tissue injuries or chronic disease situations when the body's regenerative process is insufficient to heal, regenerative medicine is quickly advancing in healthcare. The most recent developments in stem cell-based treatments for regenerative medicine are covered in this review, focusing on mesenchymal stem cell-based treatments because these cells have received the most clinical research. The most recent applications of artificial intelligence algorithms in stem cell-based therapeutics are presented, along with their limitations and potential future applications.
Export Options
About this article
Cite this article as:
Goyal Priyanshi and Malviya Rishabha*, Developments in Stem Cell Therapy by Utilizing Artificial Intelligence, Current Pharmaceutical Design 2023; 29 (28) . https://dx.doi.org/10.2174/0113816128266696230926094423
DOI https://dx.doi.org/10.2174/0113816128266696230926094423 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employed in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, and prediction, to monitoring of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Proatherogenic Importance of Carbamylation-induced Protein Damage and Type 2 Diabetes Mellitus: A Systematic Review
Current Diabetes Reviews Piperidine Nucleus as a Promising Scaffold for Alzheimer’s Disease: Current Landscape and Future Perspective
Current Topics in Medicinal Chemistry Current Management of Traumatic Rupture of the Descending Thoracic Aorta
Current Cardiology Reviews Functional Activity and Connectivity Differences of Five Resting-State Networks in Patients with Alzheimer’s Disease or Mild Cognitive Impairment
Current Alzheimer Research Impact of Diabetes in Blood-Testis and Blood-Brain Barriers: Resemblances and Differences
Current Diabetes Reviews Thyroid Hormone-Induced Angiogenesis
Current Cardiology Reviews The Human Leukocyte Antigen Class III Haplotype Approach: New Insight in Alzheimer's Disease Inflammation Hypothesis
Current Alzheimer Research The Role of the Platelet Glycoprotein IIb / IIIa in Thrombosis and Haemostasis
Current Pharmaceutical Design Oxidative Stress and Inflammation: Their Role in the Pathogenesis of Peripheral Artery Disease with or Without Type 2 Diabetes Mellitus
Current Vascular Pharmacology Ameliorative Effects of Essential Oils on Diabetes Mellitus: A Review
Current Topics in Medicinal Chemistry Preface [Hot Topic: Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]
Current Pharmaceutical Design Contrast Medium Induced Nephropathy: New Insights into Prevention and Risk Management
Cardiovascular & Hematological Agents in Medicinal Chemistry Functional and Structural Alterations of Large Arteries: Methodological Issues
Current Pharmaceutical Design Nanostructured Lipidic Carriers for Oral Bioavailability Enhancement
Recent Patents on Nanomedicine Carotid and Vertebral Arterial Variations in Alzheimer's Disease
Current Alzheimer Research Sarcopenic Obesity and Its Impact on Quality of Life: A Concise Review
Current Aging Science Diagnostic Value of 320-Slice Coronary CT Angiography in Coronary Artery Disease: A Systematic Review and Meta-Analysis
Current Medical Imaging Synergism Effects of Ursolic Acid Supplementation on the Levels of Irisin, C-reactive Protein, IL-6, and TNF-α During High-intensity Resistance Training in Low Activity Men
Cardiovascular & Hematological Disorders-Drug Targets Overview of the Diagnosis of Cytomegalovirus Infection
Infectious Disorders - Drug Targets Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis
Current Drug Targets